title: Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding.
abstract: The calcitonin receptor-like receptor (CRLR), a class B GPCR, forms a heterodimer with receptor activity-modifying protein 2 (RAMP2), and serves as the adrenomedullin (AM) receptor to control neovascularization, while CRLR and RAMP1 form the calcitonin gene-related peptide (CGRP) receptor. Here, we report the crystal structures of the RAMP2 extracellular domain alone and in the complex with the CRLR extracellular domain. The CRLR-RAMP2 complex exhibits several intermolecular interactions that were not observed in the previously reported CRLR-RAMP1 complex, and thus the shape of the putative ligand-binding pocket of CRLR-RAMP2 is distinct from that of CRLR-RAMP1. The CRLR-RAMP2 interactions were confirmed for the full-length proteins on the cell surface by site-specific photo-crosslinking. Mutagenesis revealed that AM binding requires RAMP2 residues that are not conserved in RAMP1. Therefore, the differences in both the shapes and the key residues of the binding pocket are essential for the ligand specificity.
authors.affiliation: RIKEN Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Japan.
authors.forename: Seisuke
authors.initials: S
authors.lastname: Kusano
authors.forename: Mutsuko
authors.initials: M
authors.lastname: Kukimoto-Niino
authors.forename: Nobumasa
authors.initials: N
authors.lastname: Hino
authors.forename: Noboru
authors.initials: N
authors.lastname: Ohsawa
authors.forename: Ken-ichi
authors.initials: K
authors.lastname: Okuda
authors.forename: Kensaku
authors.initials: K
authors.lastname: Sakamoto
authors.forename: Mikako
authors.initials: M
authors.lastname: Shirouzu
authors.forename: Takayuki
authors.initials: T
authors.lastname: Shindo
authors.forename: Shigeyuki
authors.initials: S
authors.lastname: Yokoyama
mesh_terms: D053607:Adrenomedullin / Q000737:chemistry / Q000378:metabolism*; D000595:Amino Acid Sequence; D058286:Calcitonin Receptor-Like Protein / Q000737:chemistry* / Q000378:metabolism*; D005110:Extracellular Space / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D008958:Models, Molecular; D008969:Molecular Sequence Data; D046912:Multiprotein Complexes / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D054730:Protein Interaction Domains and Motifs / Q000502:physiology*; D020836:Protein Structure, Quaternary; D058263:Receptor Activity-Modifying Protein 2 / Q000737:chemistry* / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D013379:Substrate Specificity
chemical_list: D058286:Calcitonin Receptor-Like Protein; D046912:Multiprotein Complexes; C545503:RAMP2 protein, human; D058263:Receptor Activity-Modifying Protein 2; D053607:Adrenomedullin
references.citation: Biochemistry. 1994 May 17;33(19):5661-73
references.pmid: 8180191
references.citation: Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13942-7
references.pmid: 17715056
references.citation: Trends Biochem Sci. 2009 Jun;34(6):303-10
references.pmid: 19446460
references.citation: Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
references.pmid: 9757107
references.citation: Biochim Biophys Acta. 2001 May 28;1539(1-2):131-9
references.pmid: 11389975
references.citation: Science. 2003 Aug 15;301(5635):964-7
references.pmid: 12920298
references.citation: J Clin Invest. 2008 Jan;118(1):29-39
references.pmid: 18097473
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
references.pmid: 20124702
references.citation: Mol Pharmacol. 2006 Jun;69(6):1984-9
references.pmid: 16531504
references.citation: Acta Crystallogr D Biol Crystallogr. 1999 Apr;55(Pt 4):849-61
references.pmid: 10089316
references.citation: J Neurosci. 2009 Jul 8;29(27):8798-804
references.pmid: 19587287
references.citation: Biochem Biophys Res Commun. 1993 Apr 30;192(2):553-60
references.pmid: 8387282
references.citation: Nature. 1998 May 28;393(6683):333-9
references.pmid: 9620797
references.citation: Nat Methods. 2005 Mar;2(3):201-6
references.pmid: 15782189
references.citation: Drug Discov Today. 2005 Mar 15;10(6):417-27
references.pmid: 15808821
references.citation: Biochem Biophys Res Commun. 2008 Dec 5;377(1):109-13
references.pmid: 18835256
references.citation: Methods Enzymol. 1997;276:307-26
references.pmid: 27754618
references.citation: Structure. 2010 Sep 8;18(9):1083-93
references.pmid: 20826335
references.citation: Bioinformatics. 1999 Apr;15(4):305-8
references.pmid: 10320398
references.citation: Proc Natl Acad Sci U S A. 2007 May 8;104(19):7875-80
references.pmid: 17470806
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5034-9
references.pmid: 18375760
references.citation: J Biol Chem. 2001 Dec 28;276(52):49459-65
references.pmid: 11591721
references.citation: J Biol Chem. 2008 Nov 21;283(47):32900-12
references.pmid: 18801728
references.citation: Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
references.pmid: 2025413
references.citation: J Struct Funct Genomics. 2004;5(1-2):63-8
references.pmid: 15263844
references.citation: J Biol Chem. 2002 Apr 26;277(17):14731-7
references.pmid: 11854283
references.citation: Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1937-40
references.pmid: 12393925
references.citation: Pharmacol Ther. 2006 Jan;109(1-2):173-97
references.pmid: 16111761
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references.pmid: 15572765
references.citation: Peptides. 2010 May;31(5):865-71
references.pmid: 20132855
references.citation: Hypertens Res. 2003 Feb;26 Suppl:S25-31
references.pmid: 12630808
references.citation: J Clin Invest. 2008 Jan;118(1):40-50
references.pmid: 18097475
references.citation: Nat Rev Drug Discov. 2002 Mar;1(3):198-210
references.pmid: 12120504
references.citation: Protein Sci. 2008 Nov;17(11):1907-14
references.pmid: 18725456
references.citation: J Biol Chem. 2008 Apr 25;283(17):11340-7
references.pmid: 18287102
references.citation: Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
references.pmid: 7984417
references.citation: Trends Pharmacol Sci. 2010 Oct;31(10):476-83
references.pmid: 20633935